Alzheimer's Disease Treatments 2021

Which FDA‑approved therapies exist for early Alzheimer’s disease and what evidence supports their use?

Two biologic therapies have been FDA‑approved to treat early Alzheimer’s disease: lecanemab (Leqembi®) and donanemab (Kisunla™), both monoclonal antibodies that target and clear beta‑amyloid plaques a...